Skip to main content
SpringerLink
Log in

Leitlinie Sklerosierungsbehandlung der Varikose

S2k-Leitlinie der Deutschen Gesellschaft für Phlebologie (DGP) in Kooperation mit folgenden Fachgesellschaften: DDG, DGA, DGG, BVP

Guidelines for sclerotherapy of varicose veins

S2k guideline of the German Society of Phlebology (DGP) in cooperation with the following professional associations: DDG, DGA, DDG, BVP. German Version

  • Leitlinien und Empfehlungen
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Rabe E, Breu FX, Cavezzi A, Coleridge Smith P, Frullini A, Gillet JL, Guex JJ, Hamel-Desnos C, Kern P, Partsch B, Ramelet AA, Tessari L, Pannier F, Guideline Group (2014) European guidelines for sclerotherapy in chronic venous disorders. Phlebology 29:338–354

    Article  CAS  PubMed  Google Scholar 

  2. Connor DE, Cooley-Andrade O, Goh WX, Ma DDF, Parsi K (2015) Detergent sclerosants are deactivated and consumed by circulating blood cells. Eur J Vasc Endovasc Surg 49:426–431

    Article  CAS  PubMed  Google Scholar 

  3. Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Franceschi C (1996) Guidelines of care for sclerotherapy treatment of varicose and teleangiectatic leg veins. J Am Acad Dermatol 34:523–528

    Article  Google Scholar 

  4. Rabe E, Pannier-Fischer F, Gerlach H, Breu FX, Guggenbichler S, Zabel M, German Society of Phlebology (2004) Guidelines for sclerotherapy of varicose veins. Dermatol Surg 30:687–693

    CAS  PubMed  Google Scholar 

  5. Hamel-Desnos C, Ouvry P, Benigni JP, Boitelle G, Schadeck M, Desnos P, Allaert FA (2007) Comparison of 1 % and 3 % polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. “the 3/1 study”. Eur J Vasc Endovasc Surg 34:723–729

    Article  CAS  PubMed  Google Scholar 

  6. Chen C‑H, Chiu C‑S, Yang C‑H (2012) Ultrasound-guided foam sclerotherapy for treating incompetent great saphenous veins—results of 5 years of analysis and morphologic evolvement study. Dermatol Surg 38:851–857

    Article  CAS  PubMed  Google Scholar 

  7. Hamel-Desnos C, Desnos P, Wollmann JC, Quvry P, Mako S, Allaert FA (2003) Evaluation of the efficacy of Polidocanol in the form of foam compared with liquid form in sclerotherapy of the long saphenous vein: Initial results. Dermatol Surg 29:1170–1175

    PubMed  Google Scholar 

  8. Alòs J, López JA, Estadella B, Serra-Prat M, Marinel-Lo J (2006) Efficacy and safety of sclerotherapy using Polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 31:101–107

    Article  PubMed  Google Scholar 

  9. Ouvry P, Allaert FA, Desnos P, Hamel-Desnos C (2008) Efficacy of polidocanol foam versus liquid in Sclerotherapy of the great Saphenous vein: a multicenter randomised controlled trial with a 2-year follow-up. Eur J Vasc Surg 36:366–370

    Article  CAS  Google Scholar 

  10. Rabe E, Otto J, Schliephake D, Pannier F (2008) Efficacy and safety of great Saphenous vein Sclerotherapy using Standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Endovasc Vasc Surg 35:238–245

    Article  CAS  Google Scholar 

  11. Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B (2011) Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg 98:1079–1087

    Article  CAS  PubMed  Google Scholar 

  12. Shadid N, Ceulen R, Nelemans P, Dirksen C, Veraart J, Schurink GW, van Neer P, Vd Kley J, de Haan E, Sommer A (2012) Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein. Br J Surg 99:1062–1070

    Article  CAS  PubMed  Google Scholar 

  13. Williamsson C, Danielsson P, Smith L (2013) Catheter-directed foam sclerotherapy for insufficiency of the great saphenous vein: occlusion rates and patient satisfaction after one year. Phlebology 28:80–85

    Article  CAS  PubMed  Google Scholar 

  14. Davies HO, Popplewell M, Darvall K, Bate G, Bradbury AW (2016) A review of randomized controlled trials comparing ultrasound-guided foam sclerotherapy with endothermal ablation for the treatment of great saphenous varicose veins. Phlebology 31:234–240

    Article  PubMed  Google Scholar 

  15. Venermo M, Saarinen J, Eskelinen E, Vähäaho S, Saarinen E, Railo M, Uurto I, Salenius J, Albäck A, Finnish Venous Study Collaborators (2016) Randomized clinical trial comparing surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy for the treatment of great saphenous varicose veins. Br J Surg 103:1438–1444

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Lawaetz M, Serup J, Lawaetz B, Bjoern L, Blemings A, Eklof B, Rasmussen L (2017) Comparison of endovenous ablation techniques, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Extended 5‑year follow-up of a RCT. Int Angiol 36:281–288

    PubMed  Google Scholar 

  17. Brittenden J, Cotton SC, Elders A, Tassie E, Scotland G, Ramsay CR, Norrie J, Burr J, Francis J, Wileman S, Campbell B, Bachoo P, Chetter I, Gough M, Earnshaw J, Lees T, Scott J, Baker SA, MacLennan G, Prior M, Bolsover D, Campbell MK (2015) Clinical effectiveness and cost-effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technol Assess 19:1–342

    Article  PubMed  PubMed Central  Google Scholar 

  18. Van der Velden SK, Biemans A, De Maeseneer M, Kockaert MA, Cuypers PW, Hollestein LM, Neumann HAM, Nijsten T, van den Bos RR (2015) Five-year results of a randomized clinical trial of conventional surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy in patients with great saphenous varicose veins. Br J Surg 102:1184–1194

    Article  PubMed  Google Scholar 

  19. Myers KA, Jolley D, Clough A, Kirwan J (2007) Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg 33:116–121

    Article  CAS  PubMed  Google Scholar 

  20. Zhang J, Jing Z, Schliephake DE, Otto J, Malouf GM, Gu YQ (2012) Efficacy and safety of Aethoxysklerol® (polidocanol) 0.5 %, 1 % and 3 % in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study). Phlebology 27:184–190

    Article  CAS  PubMed  Google Scholar 

  21. Guex JJ (2000) Ultrasound guided Sclerotherapy (USGS) for perforating veins. Hawaii Med J 59:261–262

    CAS  PubMed  Google Scholar 

  22. Masuda EM, Kessler DM, Lurie F, Puggioni A, Kistner RL, Eklof B (2006) The effect of ultrasound guided sclerotherapy of incompetent perforator veins on venous clinical severity scores. J Vasc Surg 43:551–556

    Article  PubMed  Google Scholar 

  23. Van Neer P, Veraart JCJM, Neumann H (2006) Posterolateral thigh perforator varicosities in 12 patients: a normal deep venous system and successful treatment with ultrasound-guided sclerotherapy. Dermatol Surg 32:1346–1352

    PubMed  Google Scholar 

  24. Guzelmansur I, Oguzkurt L, Koca N, Andic C, Gedikoglu M, Ozkan U (2014) Endovenous laser ablation and sclerotherapy for incompetent vein of Giacomini. Phlebology 29(8):511–516

    Article  PubMed  Google Scholar 

  25. Kahle B, Leng K (2004) Efficacy of sclerotherapy in varicose veins—a prospective, blinded placebocontrolled study. Dermatol Surg 30:723–728

    PubMed  Google Scholar 

  26. Norris MJ, Carlin MC, Ratz JL (1989) Treatment of essential telangiectasias: effects of increasing concentrations of polidocanol. J Am Acad Dermatol 20:643–649

    Article  CAS  PubMed  Google Scholar 

  27. Rabe E, Schliephake D, Otto J, Breu FX, Pannier F (2010) Sclerotherapy of telangiectasias and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). Phlebology 25:124–131

    Article  CAS  PubMed  Google Scholar 

  28. Uncu H (2010) Sclerotherapy: a study comparing polidocanol in foam and liquid form. Phlebology 25:44–49

    Article  CAS  PubMed  Google Scholar 

  29. Peterson JD, Goldman MP, Weiss RA, Duffy DM, Fabi SG, Weiss MA, Guiha I (2012) Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline. Dermatol Surg 38:1–9

    Article  CAS  Google Scholar 

  30. Parlar B, Blazek C, Cazzaniga S, Naldi L, Kloetgen HW, Borradori L, Buettiker U (2015) Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial. J Eur Acad Dermatol Venereol 29:549–554

    Article  CAS  PubMed  Google Scholar 

  31. Kakkos SK, Bountouroglou DG, Azzam M, Kalodiki E, Daskalopoulos M, Geroulakos G (2006) Effectiveness and safety of ultrasound-guided foam Sclerotherapy for recurrent varicose veins: immediate results. J Endovascular Ther 13:357–364

    Article  Google Scholar 

  32. McDonagh B, Sorenson S, Gray C, Huntley DE, Putterman P, King T, Eaton T, Martin C, Harry JL, Cohen A, Guptan RC (2003) Clinical spectrum of recurrent postoperative varicose veins and efficacy of sclerotherapy management using the compass technique. Phlebology 18:173–186

    Article  Google Scholar 

  33. Coleridge Smith P (2006) Chronic venous disease treated by ultrasound guided foam Sclerotherapy. Eur J Vasc Endovasc Surg 32:577–583

    Article  PubMed  Google Scholar 

  34. Coleridge Smith P (2009) Sclerotherapy and foam sclerotherapy for varicose veins. Phlebology 24:260–269

    Article  CAS  PubMed  Google Scholar 

  35. Bradbury AW, Bate G, Pang K, Darvall KA, Adam DJ (2010) Ultrasound-guided foam sclerotherapy is a safe and clinically effective treatment for superficial venous reflux. J Vasc Surg 52:939–945

    Article  PubMed  Google Scholar 

  36. Darvall KA, Bate GR, Adam DJ, Silverman SH, Bradbury AW (2011) Duplex ultrasound outcomes following ultrasound guided foam sclerotherapy of symptomatic recurrent great saphenous varicose veins. Eur J Vasc Endovasc Surg 42:107–114

    Article  CAS  PubMed  Google Scholar 

  37. Darvall KA, Bate GR, Adam DJ, Silverman SH, Bradbury A (2011) Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic recurrent great saphenous varicose veins. Eur J Vasc Endovasc Surg 42:107–114

    Article  CAS  PubMed  Google Scholar 

  38. De Maeseneer M (2011) Surgery for recurrent varicose veins: toward a less-invasive approach? Perspect Vasc Surg Endovasc Ther 23:244–249

    Article  PubMed  Google Scholar 

  39. Pavei P, Vecchiato M, Spreafico G, Giraldi E, Ferrini M, Baccaglini U, Ancona E (2008) Natural history of recurrent varices undergoing reintervention: a retrospective study. Dermatol Surg 34:1676–1682

    CAS  PubMed  Google Scholar 

  40. Sukovatykh BS, Rodionov OA, Sukovatykh MB, Khodykin SP (2008) Diagnosis and treatment of atypical forms of varicose disease of pelvic veins. Vestnik Khirurgii Imeni Grekova 167:43–45

    CAS  Google Scholar 

  41. Paraskevas P (2011) Successful ultrasound-guided foam sclerotherapy for vulval and leg varicosities secondary to ovarian vein reflux: a case study. Phlebology 26:29–31

    Article  CAS  PubMed  Google Scholar 

  42. Herwig R, Sansalone S (2015) Venous leakage treatment revisited: Pelvic venoablation using Aethoxysclerol under air block technique and valsalva maneuver. Arch Ital Urol Androl 87:1–4

    Article  CAS  PubMed  Google Scholar 

  43. Stücker M, Reich S, Hermes N, Altmeyer P (2006) Safety and efficiency of perilesional sclerotherapy in leg ulcer patients with postthrombotic syndrome and/or oral anticoagulation with phenprocoumon. J Dtsch Dermatol Ges 4:734–738

    Article  PubMed  Google Scholar 

  44. De Waard MM, Der Kinderen DJ (2005) Duplex ultrasonography-guided foam sclerotherapy of incompetent perforator veins in a patient with bilateral venous leg ulcers. Dermatol Surg 31:580–583

    Article  PubMed  Google Scholar 

  45. Hertzman PA, Owens R (2007) Rapid healing of chronic venous ulcers following ultrasound-guided foam sclerotherapy. Phlebology 22:34–39

    Article  CAS  PubMed  Google Scholar 

  46. Pang KH, Bate GR, Darvall KAL, Adam DJ, Bradbury AW (2010) Healing and recurrence rates following ultrasound guided foam sclerotherapy of superficial venous reflux in patients with chronic venous ulceration. Eur J Vasc Endovasc Surg 40:790–795

    Article  CAS  PubMed  Google Scholar 

  47. Williamsson C, Danielsson P, Smith L (2014) Catheter-directed foam sclerotherapy for chronic venous leg ulcers. Phlebology 29:688–693

    Article  PubMed  Google Scholar 

  48. Campos W, Torres IO, da Silva ES, Casella IB, Puech-Leão P (2015) A prospective randomized study comparing polidocanol foam sclerotherapy with surgical treatment of patients with primary chronic venous insufficiency and ulcer. Ann Vasc Surg 29:1128–1135

    Article  PubMed  Google Scholar 

  49. Lloret P, Redondo P, Cabrera J, Sierra A (2015) Treatment of venous leg ulcers with ultrasound-guided foam sclerotherapy: healing, long-term recurrence and quality of life evaluation. Wound Repair Regen 23:369–378

    Article  PubMed  Google Scholar 

  50. Neto FC, de Araújo GR, Kessler IM, de Amorim RFB, Falcão DP (2015) Treatment of severe chronic venous insufficiency with ultrasound-guided foam sclerotherapy: a two-year series in a single center in Brazil. Phlebology 30:113–118

    Article  PubMed  Google Scholar 

  51. Yamaki T, Nozaki M, Sasaki K (2000) Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 26:323–328

    Article  CAS  PubMed  Google Scholar 

  52. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T (2008) Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 47:578–584

    Article  PubMed  Google Scholar 

  53. Blaise S, Charavin-Cocuzza M, Riom H, Brix M, Seinturier C, Diamand JM, Gachet G, Carpentier PH (2011) Treatment of low-flow vascular malformations by ultrasound-guided Sclerotherapy with Polidocanol foam: 24 cases and literature review. Eur J Vasc Endovasc Surg 41:412–417

    Article  CAS  PubMed  Google Scholar 

  54. Markovic JN, Kim CY, Lidsky ME, Shortell CK (2012) A 6‑year experience treating vascular malformations with foam Sclerotherapy. Perspect Vasc Surg Endovasc Ther 24:70–79

    Article  PubMed  Google Scholar 

  55. Van der Vleuten CJM, Kater A, Wijnen MHWA, Schultze Kool LJ, Rovers MM (2014) Effectiveness of Sclerotherapy, surgery, and laser therapy in patients with venous malformations: a systematic review. Cardiovasc Intervent Radiol 37:977–989

    PubMed  Google Scholar 

  56. Chen AW, Liu YR, Zhang K, Wang T, Liu SH (2015) Efficacy of sclerotherapy with radio-opaque foam guided by digital subtraction angiography for the treatment of complex venous malformations of the head and neck. Br J Oral Maxillofac Surg 53:809–813

    Article  PubMed  Google Scholar 

  57. Horbach SER, Lokhorst MM, Saeed P, De Pontouraude CMF, Rothova A, Van der Horst CMAM (2016) Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic Review of sclerosing agents. J Plast Reconstr Aesthet Surg 69(3):295–304

    Article  PubMed  Google Scholar 

  58. Kern P, Ramelet A‑A, Wutschert R, Bounameaux H, Hayoz D (2004) Single blind randomized study comparing chromated glycerin, polidocanol solution and polidocanol foam for treatment of telangiectactic leg veins. Dermatol Surg 30:367–372

    PubMed  Google Scholar 

  59. Rabe E, Pannier F, Gerlach H, Breu FX, Guggenbichler S, Wollmann JC (2008) Leitlinie Sklerosierungsbehandlung der Varikose. Phlebologie 37:27–34

    Article  Google Scholar 

  60. Rao J, Wildemore JK, Goldmann MP (2005) Double-blind prospective comparative trial between foamed and liquid Polidocanol and Natrium Tetradecyl Sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg 31:631–635

    Article  CAS  PubMed  Google Scholar 

  61. Bullens-Goessens YIJM, Mentink LF et al (2004) Ultrasound-guided sclerotherapy of the insufficient short saphenous vein. Phlebol Ger 33:89–91

    Article  Google Scholar 

  62. Schultz-Ehrenburg U, Tourbier H (1984) Doppler-kontrollierte Verödungsbehandlung der Vena saphena magna. Phlebol Proktol 13:117–122

    Google Scholar 

  63. Vin F (1997) Principes de la Sclérothéraphie des Troncs Saphènes Internes. Phlebologie 50:229–234

    Google Scholar 

  64. Gohel MS, Epstein DM, Davies AH (2010) Cost-effectiveness of traditional and endovenous treatments for varicose veins. Br J Surg 97:1815–1823

    Article  CAS  PubMed  Google Scholar 

  65. Biemans AAM, Kockaert M, Akkersdijk GP, van den Bos RR, de Maeseneer MGR, Cuypers P, Stijne T, Neumann MHA, Nijsten T (2013) Comparing endovenous laser ablation, foam sclerotherapy, and conventional surgery for great saphenous varicose veins. J Vasc Surg 58:727–734

    Article  PubMed  Google Scholar 

  66. Rasmussen L, Lawaetz M, Serup J, Bjoern L, Vennits B, Blemings A, Eklof B (2013) Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy, and surgical stripping for great saphenous varicose veins with 3‑year follow-up. J Vasc Surg Venous Lymphat Disord 1:349–356

    Article  PubMed  Google Scholar 

  67. Carroll C, Hummel S, Leaviss J, Re S, Stevens JW, Cantrell A, Michaels J (2015) Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins. Br J Surg 101:1040–1052

    Article  Google Scholar 

  68. Nesbitt C, Bedenis R, Bhattacharya V, Stansby G (2014) Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD005624.pub3

    Article  PubMed  Google Scholar 

  69. National Institute for Health and Care of Excellence (2013) Ultrasound-guided foam sclerotherapy for varicose veins. NICE interventional procedure guidance [IPG440]

    Google Scholar 

  70. Siribumrungwong B, Noorit P, Wilasrusmee C, Leelahavarong P, Thakkinstian A, Teerawattananon Y (2016) Cost-utility analysis of great saphenous vein ablation with radiofrequency, foam and surgery in the emerging health-care setting of Thailand. Phlebology 31:573–581

    Article  PubMed  Google Scholar 

  71. Varisolve European Phase III Investigators Group, Wright D, Gobin JP, Bradbury AW et al (2006) Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology 21:180–190

    Article  Google Scholar 

  72. Cavezzi A, Frullini A, Ricci S, Tessari L (2002) Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 17:13–18

    Article  Google Scholar 

  73. Hamel-Desnos C, Ouvry P, Desnos P et al (2003) Sclérothérapie et thrombophilie: Démarche pour un consensus dans la sclérothérapie chez les thrombophiles. Phlebologie 56:165–169

    Google Scholar 

  74. Gohel MS, Heatley F, Liu X, Bradbury A, Bulbulia R, Cullum N, Epstein DM, Nyamekye I, Poskitt KR, Renton S, Warwick J, Davies AH (2018) A randomized trial of early endovenous ablationin venous ulceration. N Eng J Med 378:2105–2114

    Article  Google Scholar 

  75. Breu FX, Guggenbichler S, Wollmann JC (2008) 2nd European Consensus Meeting on Foam Sclerotherapy, 28–30 April 2006, Tegernsee, Germany. Vasa 37(Supplement 71):1–32

    Article  PubMed  Google Scholar 

  76. Guex JJ (2005) Les contre-indications de la sclérothérapie, mise à jour 2005. J Mal Vasc 30:144–149

    Article  PubMed  Google Scholar 

  77. Hamel-Desnos CM, Gillet J‑L, Desnos PR, Allaert FA (2009) Sclerotherapy of varicose veins in patients with documented thrombophilia: a prospective controlled randomized study of 105 cases. Phlebology 24:176–182

    Article  CAS  PubMed  Google Scholar 

  78. Gachet G, Spini L (2002) Sclérothérapie des varices sous anticoagulants. Phlebologie 55:41–44

    Google Scholar 

  79. Rathbun S, Norris A, Stoner J (2012) Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders. Phlebology 27:105–117

    Article  CAS  PubMed  Google Scholar 

  80. Guex JJ, Allaert F‑A, Gillet J‑L (2005) Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 31:123–128

    Article  CAS  PubMed  Google Scholar 

  81. Guex JJ (2010) Complications of sclerotherapy: an update. Dermatol Surg 36:1056–1063

    Article  CAS  PubMed  Google Scholar 

  82. Munavalli GS, Weiss RA (2007) Complications of sclerotherapy. Semin Cutan Med Surg 26:22–28

    Article  CAS  PubMed  Google Scholar 

  83. Weiss RA, Weiss MA (1990) Incidence of side effects in the treatment of telangiectasias by compression Sclerotherapy: hypertonics saline vs. polidocanol. J Dermatol Surg Oncol 16:800–804

    Article  CAS  PubMed  Google Scholar 

  84. Gillet JL, Guedes JM, Guex JJ et al (2009) Side effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 24:131–138

    Article  PubMed  Google Scholar 

  85. Cavezzi A, Parsi K (2012) Complications of foam sclerotherapy. Phlebology 27(Suppl 1):46–51

    Article  PubMed  Google Scholar 

  86. Sarvananthan T, Shepherd AC, Willenberg T, Davies AH (2012) Neurological complications of sclerotherapy for varicose veins. J Vasc Surg 55:243–251

    Article  PubMed  Google Scholar 

  87. Feied CF, Jackson JJ, Bren TS, Bond OB, Fernando CE, Young VC, Hashemiyoon RB (1994) Allergic reactions to Polidocanol for vein sclerosis. J Dermatol Surg Oncol 20:466–468

    Article  CAS  PubMed  Google Scholar 

  88. Pradalier A, Vincent D, Hentschel V et al (1995) Allergie aux sclérosants des varices. Rev Fr Allergol 35:440–443

    Google Scholar 

  89. Hannaford PKP (2016) Intra-arterial injection of sclerosants: report of three cases treated with systemic steroids. Phlebology 31:241–250

    Article  PubMed  Google Scholar 

  90. Oesch A, Stirnemann P, Mahler F (1984) The acute Ischemic syndrome of the foot after Sclerotherapy of varicose veins. Schweiz Med Wochenschr 114:1155–1158

    CAS  PubMed  Google Scholar 

  91. Grommes J, Franzen EL, Binnebösel M, Toonder IM, Wittens C, Jacobs M, Greiner A (2010) Inadvertent arterial injection using catheter-assisted sclerotherapy resulting in amputation. Dermatol Surg 37:536–538

    Article  PubMed  CAS  Google Scholar 

  92. Hafner F, Fröhlich H, Gary T, Brodmann M (2013) Intra-arterial injection, a rare but serious complication of sclerotherapy. Phlebology 28:64–73

    Article  CAS  PubMed  Google Scholar 

  93. Goldman MP, Sadick NS, Weiss RA (1995) Cutaneous necrosis, telangiectatic matting and hyperpigmentation following Sclerotherapy. Dermatol Surg 21:19–29

    Article  CAS  PubMed  Google Scholar 

  94. Schuller-Petrović S, Brunner F, Neuhold N, Pavlović MD, Wölkart G (2011) Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy. J Eur Acad Dermatol Venereol 25:983–986

    Article  PubMed  CAS  Google Scholar 

  95. Bergan JJ, Weiss RA, Goldman MP (2000) Extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg 26:535–542

    Article  CAS  PubMed  Google Scholar 

  96. Bihari I, Magyar É (2001) Reasons for ulceration after injection treatment of telangiectasia. Dermatol Surg 27:133–136

    CAS  PubMed  Google Scholar 

  97. Geukens J, Rabe E, Bieber T (1999) Embolia cutis medicamentosa of the foot after sclerotherapy. Eur J Dermatol 9:132–133

    CAS  PubMed  Google Scholar 

  98. Ramelet AA, Parmentier L (2010) Delayed Nicolau’s Livedoid dermatitis after ultrasound-guided Sclerotherapy. Dermatol Surg 36:155–158

    Article  CAS  PubMed  Google Scholar 

  99. Van der Plas JPL, Lambers JC, van Wersch JW, Koehler PJ (1994) Reversible ischaemic neurological deficit after sclerotherapy of varicose veins. Lancet 343:428

    Article  PubMed  Google Scholar 

  100. Künzelberger B, Pieck C, Altmeyer P, Stücker M (2006) Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1 % polidocanol. Derm Surg 32:1410

    Google Scholar 

  101. Hill DA (2014) Neurological and chest symptoms following sclerotherapy: a single centre experience. Phlebology 29:619–627

    Article  PubMed  Google Scholar 

  102. Willenberg T, Smith PC, Shepherd A, Davies AH (2013) Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review. Phlebology 28:123–131

    Article  CAS  PubMed  Google Scholar 

  103. Parsi K (2012) Paradoxical embolism, stroke and sclerotherapy. Phlebology 27:147–167

    Article  CAS  PubMed  Google Scholar 

  104. Parsi K (2011) Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications. Phlebology 26:140–147

    Article  CAS  PubMed  Google Scholar 

  105. Morrison N, Cavezzi A, Bergan J, Partsch H (2006) Regarding “stroke after varicose vein foam injection sclerotherapy”. J Vasc Surg 44:224–225

    Article  PubMed  Google Scholar 

  106. Passariello F (2007) Sclerosing foam and patent foramen ovale. The final report. In: Word Congress of the International Union of Phlebology; Int Angiol, Bd. 26, S 87

    Google Scholar 

  107. Wagdi P (2006) Migräne und offenes Foramen Ovale: nur ein vorübergehender Hoffnungsschimmer? Kardiovasc Med 9:32–36

    Google Scholar 

  108. Gillet JL, Donnet A, Lausecker M, Guedes JM, Guex JJ, Lehmann P (2010) Pathophysiology of visual disturbances occurring after foam sclerotherapy. Phlebology 25:261–266

    Article  CAS  PubMed  Google Scholar 

  109. Zouitina TM, Hyra M, Seryer D, Chillon J‑M, Bugnicourt J‑M (2014) Prolonged acute migraine with aura and reversible brain MRI abnormalities after liquid sclerotherapy. J Headache Pain 15:1–4

    Article  Google Scholar 

  110. Frullini A, Felice F, Burchielli S, Di Stefano R (2011) High production of endothelin after foam sclerotherapy: a new pathogenetic hypothesis for neurological and visual disturbances after sclerotherapy. Phlebology 26:203–208

    Article  CAS  PubMed  Google Scholar 

  111. Frullini A, Barsotti MC, Santoni T, Duranti E, Burchielli S, Di Stefano R (2012) Significant endothelin release in patients treated with foam sclerotherapy. Dermatol Surg 38:741–747

    Article  CAS  PubMed  Google Scholar 

  112. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T (2008) Multiple Small-Dose Injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg 37:343–348

    Article  PubMed  Google Scholar 

  113. Forlee MV, Grouden M, Moore DJ, Shanik G (2006) Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 43:162–164

    Article  PubMed  Google Scholar 

  114. Busch RG, Derrick M, Manjoney D (2008) Major neurological events following foam sclerotherapy. Phlebology 23:189–192

    Article  Google Scholar 

  115. Leslie-Mazwi TM, Avery LL, Sims JR (2009) Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy. Neurocrit Care 11:97–100

    Article  CAS  PubMed  Google Scholar 

  116. De Laney MC, Bowe CT, Higgins GL III (2010) Acute stroke from air embolism after leg Sclerotherapy. West J Emerg Med 11:397

    Google Scholar 

  117. Ma RWL, Pilotelle A, Paraskevas P, Parsi K (2011) Three cases of stroke following peripheral venous interventions. Phlebology 26:280–284

    Article  CAS  PubMed  Google Scholar 

  118. Harzheim M, Becher H, Klockgether T (2000) Brain infarct from a paradoxical embolism following a varices operation. Dtsch Med Wochenschr 125:794–796

    Article  CAS  PubMed  Google Scholar 

  119. Caggiati A, Franceschini M (2010) Stroke following endovenous laser treatment of varicose veins. J Vasc Surg 51:218–220

    Article  PubMed  Google Scholar 

  120. Gillet JL (2011) Neurological complications of foam sclerotherapy: fears and reality. Phlebology 26:277–279

    Article  PubMed  Google Scholar 

  121. Deichman B, Blum G (1995) Cerebrovascular accident after sclerotherapy. Phlebologie 24:148–152

    Google Scholar 

  122. Kas A, Begue M, Nifle C, Gil R, Neau JP (2000) Infarctus cérébelleux après sclérothérapie de varicosités des membres inférieurs. Presse Med 29:1935

    CAS  PubMed  Google Scholar 

  123. Hanisch F, Müller T, Krivocuca M, Winterholler M (2004) Stroke following variceal sclerotherapy. Eur J Med Res 9:282–284

    PubMed  Google Scholar 

  124. Picard C, Deltombe B, Duru C, Godefroy O, Bugnicourt JM (2010) Foam sclerotherapy: a possible cause of ischaemic stroke? J Neurol Neurosurg Psychiatry 81:582–583

    Article  PubMed  Google Scholar 

  125. Hahn M, Shulz T, Juenger M (2010) Late stroke after foam sclerotherapy. Vasa 39:108–110

    Article  CAS  PubMed  Google Scholar 

  126. Guex JJ (1996) Thombotic complications of the varicose disease. J Dermatol Surg 22:378–382

    CAS  Google Scholar 

  127. Hamel-Desnos C, Desnos P, Ferré B, Le Querrec A (2011) In vivo biological effects of foam sclerotherapy. Eur J Vasc Endovasc Surg 42:238–245

    Article  CAS  PubMed  Google Scholar 

  128. Fabi SG, Peterson JD, Goldman MP, Guiha I (2012) An investigation of coagulation cascade activation and induction of Fibrinolysis using foam Sclerotherapy of reticular veins. Dermatol Surg 38:367–372

    Article  CAS  PubMed  Google Scholar 

  129. Jia X, Mowatt G, Burr JM, Cassar K, Cooke J, Fraser C (2007) Systematic review of foam sclerotherapy for varicose veins. Br J Surg 94:925–936

    Article  CAS  PubMed  Google Scholar 

  130. Dermody M, Schul MW, O’Donnell TF (2015) Thromboembolic complications of endovenous thermal ablation and foam sclerotherapy in the treatment of great saphenous vein insufficiency. Phlebology 30:357–364

    Article  PubMed  Google Scholar 

  131. Myers KA, Jolley D (2008) Factors affecting the risk of deep venous occlusion after ultrasound-guided Sclerotherapy for varicose vein. Eur J Vasc Endovasc Surg 36:602–605

    Article  CAS  PubMed  Google Scholar 

  132. Reich-Schupke S, Doerler M, Altmeyer P, Stücker M (2013) Foam sclerotherapy with enoxaparin prophylaxis in high-risk patients with postthrombotic syndrome. Vasa 42:50–55

    Article  PubMed  Google Scholar 

  133. Zipper SG (2000) Nervus peronäus-Schaden nach Varizensklerosierung mit Aethoxysklerol. Versicherungsmedizin 4:185–187

    Google Scholar 

  134. Reich-Schupke S, Weyer K, Altmeyer P, Stücker M (2010) Treatment of varicose tributaries with sclerotherapy with polidocanol 0.5 % foam. Vasa 39:169–174

    Article  CAS  PubMed  Google Scholar 

  135. Georgiev MJ (1990) Postsclerotherapy hyperpigmentations: a one-year follow-up. Dermatol Surg Oncol 16:608–610

    Article  CAS  Google Scholar 

  136. Scultetus AH, Villavicencio JL, Kao TC, Gillespie DL, Ketron GD, Iafrati MD, Pikoulis E, Eifert S (2003) Microthrombectomy reduces postsclerotherapy pigmentation: multicenter randomized trial. J Vasc Surg 38:896–903

    Article  PubMed  Google Scholar 

  137. Goldman MP, Kaplan RP, Duffy DM (1987) Postsclerotherapy hyperpigmentation: a histologic evaluation. J Dermatol Surg Oncol 13:547–550

    Article  CAS  PubMed  Google Scholar 

  138. Davis LT, Duffy DM (1990) Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Etiology, prevention, and treatment. J Dermatol Surg Oncol 16:327–330

    Article  CAS  PubMed  Google Scholar 

  139. Ramelet A‑A (2010) Phlébologie esthétique. Télangiectasies : possibilités thérapeutiques. Cosmétologie et Dermatologie esthétique. EMC (Elsevier Masson SAS), Paris

    Google Scholar 

  140. Morrison N, Neuhardt DL, Rogers CR, McEown J, Morrison T, Johnson E, Salles-Cunha SX (2008) Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 47:830–836

    Article  PubMed  Google Scholar 

  141. Morrison N, Neuhardt DL, Rogers CR, McEown J, Morrison T, Johnson E, Salles-Cunha SX (2010) Incidence of side effects using carbon dioxide oxygen foam for chemical ablation of superficial veins of the lower extremity. Eur J Vasc Endovasc Surg 40:407–413

    Article  CAS  PubMed  Google Scholar 

  142. Beckitt T, Elstone A, Ashley S (2011) Air versus physiological gas for ultrasound guided foam Sclerotherapy treatment of varicose veins. Eur J Vasc Endovasc Surg 42:115–119

    Article  CAS  PubMed  Google Scholar 

  143. Hesse G, Breu FX, Kuschmann A, Hartmann K, Salomon N (2012) Sclerotherapy using air- or CO2-O2-foam: post-approval study. Phlebologie 41:77–88

    Article  Google Scholar 

  144. Mercer KG, Scott DJ, Berridge DC (1998) Preoperative duplex imaging is required before all operations for primary varicose veins. Br J Surg 85:1495–1497

    Article  CAS  PubMed  Google Scholar 

  145. Blomgren L, Johansson G, Bergquist D (2005) Randomized clinical trial of routine preoperative duplex imaging before varicose vein surgery. Br J Surg 92:688–694

    Article  CAS  PubMed  Google Scholar 

  146. Coleridge-Smith P, Labropoulos N, Partsch H, Myers K, Nicolaides A, Cavezzi A (2006) Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs—UIP consensus document. Part I. Basic principles. Eur J Vasc Endovasc Surg 31:83–92

    Article  CAS  PubMed  Google Scholar 

  147. De Maeseneer M, Pichot O, Cavezzi A, Earnshaw J, van Rij A, Lurie F, Smith PC (2011) Duplex ultrasound investigation of the veins of the lower limbs after treatment for varicose veins—UIP consensus document. Eur J Vasc Endovasc Surg 42:89–102

    Article  PubMed  Google Scholar 

  148. Rautio T, Perälä J, Biancari F, Wiik H, Ohtonen P, Haukipuro K, Juvonen T (2002) Accuracy of hand-held Doppler in planning the operation for primary varicose veins. Eur J Vasc Endovasc Surg 24:450–455

    Article  CAS  PubMed  Google Scholar 

  149. Franco G (1998) Explorations ultrasonographiques des récidives variqueuses post-chirurgicales. Phlebologie 51:403–413

    Google Scholar 

  150. Jiang P, van Rij AM, Christie R, Hill G, Solomon C, Thomson I (1999) Recurrent varicose veins: patterns of reflux and clinical severity. Cardiovasc Surg 7:332–339

    Article  CAS  PubMed  Google Scholar 

  151. Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH (2003) Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 37:533–538

    Article  CAS  PubMed  Google Scholar 

  152. Bihari I, Tasnadi G, Bihari P (2003) Importance of subfascial collaterals in deep-vein malformations. Dermatol Surg 29:146–149

    PubMed  Google Scholar 

  153. Brunken A, Rabe E, Pannier F (2009) Changes in venous function after foam sclerotherapy of varicose veins. Phlebology 24:145–150

    Article  CAS  PubMed  Google Scholar 

  154. Darvall KAL, Sam RC, Bate GR, Adam DJ, Bradbury AW (2010) Photoplethysmographic venous refilling times following ultrasound guided foam Sclerotherapy for symptomatic superficial venous reflux: relationship with clinical outcomes. Eur J Vasc Endovasc Surg 40:267–272

    Article  CAS  PubMed  Google Scholar 

  155. Kreussler: Fachinformationen Aethoxysklerol® 0,25 %/0,5 %/1 %/2 %/3 % Stand August 2015, Chemische Fabrik Kreussler & Co GmbH

  156. Wollmann JC (2004) The history of sclerosing foams. Dermatol Surg 30:694–703

    PubMed  Google Scholar 

  157. Sadoun S, Benigni JP, Sica M (2002) Étude prospective de l’efficacité de la mousse de sclérosant dans le traitement des varices tronculaires des membres inférieurs. Phlebologie 55:259–262

    Google Scholar 

  158. Tessari L, Cavezzi A, Frullini A (2001) Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 27:58–60

    CAS  PubMed  Google Scholar 

  159. De Roos KP, Groen L, Leenders AC (2011) Foam sclerotherapy: investigating the need for sterile air. Dermatol Surg 37:1119–1124

    Article  PubMed  CAS  Google Scholar 

  160. Guex JJ, Hamel-Desnos C, Gillet JL, Chleir F, Perrin M (2008) Sclérothérapie des varices par mousse écho-guidée: techniques de mise en œuvre, indications, résultats publiés. Phlebologie 61:261–270

    Google Scholar 

  161. Yamaki T, Hamahata A, Soejima K, Kono T, Nozaki M, Sakurai H (2012) Prospective randomised comparative study of visual foam Sclerotherapy alone or in combination with ultrasound-guided foam sclerotherapy for treatment of superficial venous insufficiency: preliminary report. Eur J Vasc Endovasc Surg 43:343–347

    Article  CAS  PubMed  Google Scholar 

  162. Blaise S, Bosson JL, Diamand JM (2010) Ultrasound-guided sclerotherapy of the great saphenous vein with 1 % vs. 3 % Polidocanol foam: a multicentre double-blind randomised trial with 3‑year follow-up. Eur J Vasc Endovasc Surg 39:779–786

    Article  CAS  PubMed  Google Scholar 

  163. Ceulen RPM, Bullens-Goessens YIJM, Pi-Van De Venne SJA (2007) Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1 % versus 3 % Polidocanol foam: Results of a randomized controlled trial with 1‑year follow-up. Dermatol Surg 33:276–281

    CAS  PubMed  Google Scholar 

  164. Yamaki T, Nozaki M, Iwasaka S (2004) Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 30:718–722

    PubMed  Google Scholar 

  165. Kanter A, Thibault P (1996) Saphenofemoral incompetence treated by ultrasound-guided sclerotherapy. Dermatol Surg 22:648–652

    CAS  PubMed  Google Scholar 

  166. Grondin L, Young R, Wouters L (1997) Sclérothérapie écho-guidée et sécurité: comparaison des techniques. Phlebologie 50:241–245

    Google Scholar 

  167. Schadeck M, Allaert FA (1997) Résultats à long terme de la Sclérothérapie des Saphènes internes. Phlebologie 50(2):257–262

    Google Scholar 

  168. Elias S, Raines JK (2012) Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial. Phlebology 27:67–72

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  169. Whiteley MS, Dos SSJ, Lee CT, Li JM (2017) Mechanochemical ablation causes endothelial and medial damage to the vein wall resulting in deeper penetration of sclerosant compared with sclerotherapy alone in extrafascial great saphenous vein using an ex vivo model. J Vasc Surg Venous Lymphat Disord 5:370–377

    Article  PubMed  Google Scholar 

  170. National Institute for Health and Care Excellence (2016) Interventional procedure overview of endovenous mechanochemical ablation for varicose veins. NICE, London (https://www.nice.org.uk/guidance/ipg557/documents/overview.)

    Google Scholar 

  171. Mechanochemical Venous Ablation for Varicose Veins (2017) Center for evidence-based policy. Oregon Health & Science University, Portland (www.ohsu.edu/policycenter)

    Google Scholar 

  172. Ramon R, van Eekeren JP, Boersma D, Konijn V, de Vries JP, Reijnen MM (2013) Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins. J Vasc Surg 57:445–450

    Article  Google Scholar 

  173. Khor SN, Kam JW, Kum S, Tan YK, Tang TY (2018) ClariVein™—One year results of mechano-chemical ablation for varicose veins in a multi-ethnic Asian population from Singapore. Phlebology. https://doi.org/10.1177/0268355518771225

    Article  PubMed  Google Scholar 

  174. van Eekeren RR, Boersma D, Konijn V, de Vries JP, Reijnen MM (2013) Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins. J Vasc Surg 57:445–450

    Article  PubMed  Google Scholar 

  175. Witte ME, Holewijn S, van Eekeren RR, de Vries JP, Zeebregts CJ, Reijnen MM (2017) Midterm outcome of mechanochemical endovenous ablation for the treatment of great Saphenous vein insufficiency. J Endovasc Ther 24:149–155

    Article  PubMed  Google Scholar 

  176. Lane T, Bootun R, Dharmarajah B, Lim CS, Najem M, Renton S, Sritharan K, Davies AH (2017) A multi-centre randomised controlled trial comparing radiofrequency and mechanical occlusion chemically assisted ablation of varicose veins—Final results of the Venefit versus Clarivein for varicose veins trial. Phlebology 32:89–98

    Article  PubMed  Google Scholar 

  177. Devereux N, Recke AL, Westermann L, Recke A, Kahle B (2014) Catheter-directed foam Sclerotherapy of great Saphenous veins in combination with pre-treatment reduction of the diameter employing the principals of perivenous tumescent local anesthesia. Eur J Vasc Endovasc Surg 47:187–195

    Article  CAS  PubMed  Google Scholar 

  178. Ceulen RPM, Jagtmann EA, Sommer A, Teule GJJ, Schurink GWH, Kemerink GJ (2010) Blocking the saphenafemoral junction during ultrasound guided foam sclerotherapy—assessment of a presumed safety-measure procedure. Eur J Vasc Endovasc Surg 40:772–776

    Article  CAS  PubMed  Google Scholar 

  179. Brodersen JP (2007) Catheter-assisted vein sclerotherapy: a new approach for sclerotherapy of the greater saphenous vein with a double-lumen balloon catheter. Dermatol Surg 33:469–475

    CAS  PubMed  Google Scholar 

  180. Wildenhues B (2005) Catheter-assisted foam sclerotherapy. A new minimally invasive method for the treatment of trunk varicosis of the long and short saphenous veins. Phlebologie 34:165–170

    Article  Google Scholar 

  181. Hahn M, Schulz T, Jünger M (2007) Sonographically guided, transcatheter foam sclerotherapy of the great saphenous vein. Medical and oeconomic aspects. Phlebologie 36:309–312

    Article  Google Scholar 

  182. Bidwai A, Beresford T, Dialynas M, Prionidis J, Panayiotopoulos Y, Bowne TF (2007) Balloon control of the saphenofemoral junction during foam sclerotherapy : proposed innovation. J Vasc Surg 46:145–147

    Article  PubMed  Google Scholar 

  183. Kölbel T, Hinchliffe RJ, Lindbal B (2007) Catheter-directed foam sclerotherapy of axial saphenous reflux. Early results. Phlebology 22:219–222

    Article  PubMed  Google Scholar 

  184. Parsi K (2009) Catheter-directed sclerotherapy. Phlebology 24:98–107

    Article  CAS  PubMed  Google Scholar 

  185. Cavezzi A, Tessari L (2009) Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection. Phlebology 24:247–251

    Article  CAS  PubMed  Google Scholar 

  186. Chapman-Smith P, Browne A (2009) Prospective five year study of ultrasound guided foam sclerotherapy in the treatment of great saphenous vein reflux. Phlebology 24:183–188

    Article  CAS  PubMed  Google Scholar 

  187. Kern P, Ramelet AA, Wütschert R, Hayoz D (2007) Compression after sclerotherapy for telangiectasiastelangiectasias and reticular leg veins. A randomized controlled study. J Vasc Surg 45:1212–1216

    Article  PubMed  Google Scholar 

  188. Weiss RA, Sadick NS, Goldman MP, Weiss MA (1999) Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg 25:105–108

    Article  CAS  PubMed  Google Scholar 

  189. Goldman MP, Beaudoing D, Marley W, Lopez L, Butie A (1990) Compression in the treatment of leg teleangiectasia: a preliminary report. J Dermatol Surg Oncol 16:322–325

    Article  CAS  PubMed  Google Scholar 

  190. Nootheti PK, Cadag KM, Magpantay A, Goldman MP (2009) Efficacy of graduated compression stockings for an additional 3 weeks after sclerotherapy treatment of reticular and telangiectatic leg veins. Dermatol Surg 35:53–58

    CAS  PubMed  Google Scholar 

  191. Hamel-Desnos C, Guias BJ, Desnos PR, Mesgard A (2010) Foam sclerotherapy of the saphenous veins. Randomised controlled trial with or without compression. Eur J Vasc Endovasc Surg 39:500–507

    Article  CAS  PubMed  Google Scholar 

  192. El-Sheikha J, Carradice D, Nandhra S, Leung HC, Smith GE, Campbell B, Chetter IC (2015) Systematic review of compression following treatment for varicose veins. Br J Surg 102:719–725

    Article  CAS  PubMed  Google Scholar 

  193. Zarca C, Bailly C, Gachet G, Spini L (2012) ClassMousse 1 study: compression hosiery and foam Sclerotherapy. Phlebologie 65:11–20

    Google Scholar 

  194. Ferrara F, Bernbach HR (2009) La compression écho-guidée après sclérothérapie. Phlebologie 62:36–41

    Google Scholar 

  195. Stanley PRW, Bickerton DR, Campbell WB (1991) Injection sclerotherapy for varicose veins—a comparison of materials for applying local compression. Phlebology 6:37–39

    Article  Google Scholar 

  196. Friedmann DP, Liolios AM, Wu DC, Goldman MP, Eimpunth S (2015) A randomized, double-blind, placebo-controlled study of the effect of a high-potency topical corticosteroid after Sclerotherapy for reticular and telangiectatic veins of the lower extremities. Dermatol Surg 41:1158–1163

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Emeritus Klinik und Poliklinik für Dermatologie und Allergologie, Universitätsklinikum Bonn (AöR), Venusberg-Campus 1, 53127, Bonn, Deutschland

    E. Rabe

  2. Bad Wiessee, Deutschland

    F. X. Breu

  3. Berlin, Deutschland

    I. Flessenkämper

  4. Viernheim, Deutschland

    H. Gerlach

  5. Praxis für Allgemeinmedizin und Phlebologie, München, Deutschland

    S. Guggenbichler

  6. Klinik für Dermatologie, Allergologie und Venerologie, Universitätsklinikum Schleswig-Holstein, Lübeck, Deutschland

    B. Kahle

  7. Phlebologische Praxis, Köln, Deutschland

    R. Murena

  8. Privatpraxis für Haut- und Gefäßmedizin, Wundtherapie, Recklinghausen, Deutschland

    S. Reich-Schupke

  9. Praxis für Gefäßmedizin, Freiburg, Deutschland

    T. Schwarz

  10. Klinik für Dermatologie, Venerologie und Allergologie Ruhr-Universität Bochum, St. Josef Hospital, 44791, Gudrunstr. 9, Bochum, Deutschland

    M. Stücker

  11. Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinik Frankfurt, Frankfurt, Deutschland

    E. Valesky

  12. Universitäts-Gefäßzentrum, Innere Medizin III, Universitätsklinikum Carl Gustav Carus, Dresden, Deutschland

    S. Werth

  13. Praxis Dermatologie & Phlebologie Bonn und Dermatologische Universitätsklinik Köln, Bonn, Deutschland

    F. Pannier

Authors
  1. E. Rabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. X. Breu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Flessenkämper
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Gerlach
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Guggenbichler
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Kahle
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Murena
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. Reich-Schupke
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. T. Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. Stücker
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. E. Valesky
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. S. Werth
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. F. Pannier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Rabe.

Ethics declarations

Interessenkonflikt

Die Dokumentation und Offenlegung potenzieller Interessenkonflikte ist online auf der Webseite http://www.awmf.org/leitlinien verfügbar.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Die S2k-Leitlinie wurde Anfang 2019 unter der AWMF-Register-Nr. 037-015 bei der AWMF online publiziert. Die Leitlinie ist bis zum 30.12.2023 gültig.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rabe, E., Breu, F.X., Flessenkämper, I. et al. Leitlinie Sklerosierungsbehandlung der Varikose. Hautarzt 72, 50–64 (2021). https://doi.org/10.1007/s00105-020-04707-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-020-04707-y

Search

Navigation